Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays

This publication has 11 references indexed in Scilit:

• Serum Free Light Chains: An Alternative to the Urine Bence Jones Proteins Screening Test for Monoclonal Gammopathies
  Clinical Chemistry, 2006
• Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
  Blood, 2005
• Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins
  American Journal of Clinical Pathology, 2005
• Diagnostic Performance of Quantitative κ and λ Free Light Chain Assays in Clinical Practice
  Clinical Chemistry, 2005
• Serum Free Light Chain Measurements Move to Center Stage
  Clinical Chemistry, 2005
• Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
  British Journal of Haematology, 2003
• Serum test for assessment of patients with Bence Jones myeloma
  The Lancet, 2003
• Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains
  Clinical Chemistry, 2002
• Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma
  Blood, 2001
• Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine
  Clinical Chemistry, 2001